Saposin A Mobilizes Lipids from Low Cholesterol and High Bis(monoacylglycerol)phosphate-containing Membranes
暂无分享,去创建一个
Ralf Klingenstein | Wolfram Saenger | W. Saenger | K. Sandhoff | Konrad Sandhoff | Silvia Locatelli-Hoops | Natascha Remmel | Bernadette Breiden | Maksim Rossocha | Maike Schoeniger | Christine Koenigs | Bernadette Breiden | N. Remmel | R. Klingenstein | M. Rossocha | S. Locatelli-Hoops | Maike Schoeniger | C. Koenigs
[1] N. Radin,et al. Cerebroside galactosidase of brain. , 1966, Journal of lipid research.
[2] M. Ho,et al. Gaucher's disease: deficiency of 'acid' -glucosidase and reconstitution of enzyme activity in vitro. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[3] J. Wherrett,et al. Enrichment of bis-(monoacylglyceryl) phosphate in lysosomes from rat liver. , 1972, The Journal of biological chemistry.
[4] W. Stremmel,et al. Bis(monoacylglycerin)phosphorsäure — ein Marker-Lipid sekundärer Lysosomen? , 1976 .
[5] N. Radin,et al. Mechanism of activation of glucocerebrosidase by co-beta-glucosidase (glucosidase activator protein). , 1981, Biochimica et biophysica acta.
[6] S. Roth,et al. A protein activator of galactosylceramide β-galactosidase , 1982 .
[7] R. Linke,et al. Immunochemical characterization of two activator proteins stimulating enzymic sphingomyelin degradation in vitro. Absence of one of them in a human Gaucher disease variant. , 1986, Biological chemistry Hoppe-Seyler.
[8] K. Sandhoff,et al. Specificity of human glucosylceramide β‐glucosidase towards synthetic glucosylsphingolipids inserted into liposomes , 1986 .
[9] I Mellman,et al. Acidification of the endocytic and exocytic pathways. , 1986, Annual review of biochemistry.
[10] B. Martin,et al. Saposin A: second cerebrosidase activator protein. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[11] S. Weiler,et al. Interaction of saposins, acidic lipids, and glucosylceramidase. , 1990, The Journal of biological chemistry.
[12] G. Grabowski,et al. Human acid beta-glucosidase. Use of inhibitory and activating monoclonal antibodies to investigate the enzyme's catalytic mechanism and saposin A and C binding sites. , 1991, The Journal of biological chemistry.
[13] R. Macdonald,et al. Small-volume extrusion apparatus for preparation of large, unilamellar vesicles. , 1991, Biochimica et biophysica acta.
[14] K. Sandhoff,et al. Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease , 1991, FEBS letters.
[15] Y. Kishimoto,et al. Saposins: structure, function, distribution, and molecular genetics. , 1992, Journal of lipid research.
[16] A. Poulos,et al. Simultaneous deficiency of sphingolipid activator proteins 1 and 2 is caused by a mutation in the initiation codon of their common gene. , 1992, The Journal of biological chemistry.
[17] B. Maras,et al. Function of saposin C in the reconstitution of glucosylceramidase by phosphatidylserine liposomes , 1993, FEBS letters.
[18] R. Salvioli,et al. Studies on glucosylceramidase binding to phosphatidylserine liposomes: the role of bilayer curvature. , 1993, Biochimica et biophysica acta.
[19] C. Ponting. Acid sphingomyelinase possesses a domain homologous to its activator proteins: Saposins B and D , 1994, Protein science : a publication of the Protein Society.
[20] X. Qi,et al. Functional human saposins expressed in Escherichia coli. Evidence for binding and activation properties of saposins C with acid beta-glucosidase. , 1994, The Journal of biological chemistry.
[21] R. Salvioli,et al. pH-dependent Conformational Properties of Saposins and Their Interactions with Phospholipid Membranes (*) , 1995, The Journal of Biological Chemistry.
[22] E. Prence. Effects of calcium on phosphatidylserine- and saposin C-stimulated glucosylceramide beta-glucosidase activity. , 1995, The Biochemical journal.
[23] K. Sandhoff,et al. Topology of glycosphingolipid degradation. , 1996, Trends in cell biology.
[24] K. Sandhoff,et al. Expression of the Three Alternative Forms of the Sphingolipid Activator Protein Precursor in Baby Hamster Kidney Cells and Functional Assays in a Cell Culture System (*) , 1996, The Journal of Biological Chemistry.
[25] N. Maeda,et al. Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids. , 1996, Human molecular genetics.
[26] W. Möbius,et al. Accumulation of sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by treatment with human SAP-precursor. , 1997, European journal of cell biology.
[27] R. Salvioli,et al. Effect of Saposins A and C on the Enzymatic Hydrolysis of Liposomal Glucosylceramide* , 1997, The Journal of Biological Chemistry.
[28] T. Linke,et al. Lysosomal Degradation on Vesicular Membrane Surfaces , 1998, The Journal of Biological Chemistry.
[29] R. Parton,et al. A lipid associated with the antiphospholipid syndrome regulates endosome structure and function , 1998, Nature.
[30] T. Linke,et al. Degradation of Membrane-bound Ganglioside GM1 , 2000, The Journal of Biological Chemistry.
[31] R. Salvioli,et al. Further studies on the reconstitution of glucosylceramidase activity by Sap C and anionic phospholipids , 2000, FEBS letters.
[32] W. Cho,et al. Mechanism of annexin I-mediated membrane aggregation. , 2000, Biochemistry.
[33] Dudley H. Williams,et al. A vesicle capture sensor chip for kinetic analysis of interactions with membrane-bound receptors. , 2000, Analytical biochemistry.
[34] W. Cho,et al. Roles of calcium ions in the membrane binding of C2 domains. , 2001, The Biochemical journal.
[35] J. Matsuda,et al. A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse. , 2001, Human molecular genetics.
[36] K. Sandhoff,et al. Degradation of membrane-bound ganglioside GM2 by beta -hexosaminidase A. Stimulation by GM2 activator protein and lysosomal lipids. , 2001, The Journal of biological chemistry.
[37] X. Qi,et al. Differential Membrane Interactions of Saposins A and C , 2001, The Journal of Biological Chemistry.
[38] K. Umebayashi. The roles of ubiquitin and lipids in protein sorting along the endocytic pathway. , 2003, Cell structure and function.
[39] K. Harzer,et al. Concurrent increase of cholesterol, sphingomyelin and glucosylceramide in the spleen from non‐neurologic Niemann–Pick type C patients but also patients possibly affected with other lipid trafficking disorders , 2003, FEBS letters.
[40] E. V. van Donselaar,et al. Recycling Compartments and the Internal Vesicles of Multivesicular Bodies Harbor Most of the Cholesterol Found in the Endocytic Pathway , 2003, Traffic.
[41] M. Patterson. A Riddle Wrapped in a Mystery: Understanding Niemann-Pick Disease, Type C , 2003, The neurologist.
[42] W. Roggendorf,et al. Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs , 1993, Human Genetics.
[43] J. Matsuda,et al. Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse. , 2004, Human molecular genetics.
[44] S. Kaufmann,et al. Saposin C is required for lipid presentation by human CD1b , 2004, Nature Immunology.
[45] M. Vanier. Lipid Changes in Niemann-Pick Disease Type C Brain: Personal Experience and Review of the Literature , 1999, Neurochemical Research.
[46] P. Savage,et al. Editing of CD1d-Bound Lipid Antigens by Endosomal Lipid Transfer Proteins , 2004, Science.
[47] A. C. Looman,et al. Efficient expression and secretion of Aspergillus niger RH5344 polygalacturonase in Saccharomyces cerevisiae , 1995, Applied Microbiology and Biotechnology.
[48] Direct AFM observation of saposin C-induced membrane domains in lipid bilayers: from simple to complex lipid mixtures. , 2004, Chemistry and physics of lipids.
[49] Michael Krauss,et al. Phosphatidylinositol-(4,5)-bisphosphate regulates sorting signal recognition by the clathrin-associated adaptor complex AP2. , 2005, Molecular cell.
[50] P. Seglen,et al. Proteases and proteolysis in the lysosome , 1992, Experientia.
[51] H. Mandel,et al. A mutation in the saposin A coding region of the prosaposin gene in an infant presenting as Krabbe disease: first report of saposin A deficiency in humans. , 2005, Molecular genetics and metabolism.
[52] A. Poulos,et al. Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: Biochemical signs of combined sphingolipidoses , 1989, European Journal of Pediatrics.
[53] A. Chabás,et al. Activator protein deficient Gaucher's disease , 1989, Klinische Wochenschrift.
[54] K. Sandhoff,et al. Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids. , 2005, Annual review of cell and developmental biology.
[55] Xiaoyang Qi,et al. Saposin C-LBPA interaction in late-endosomes/lysosomes. , 2005, Experimental cell research.
[56] M. Leippe,et al. Lipid-binding Proteins in Membrane Digestion, Antigen Presentation, and Antimicrobial Defense* , 2005, Journal of Biological Chemistry.